63 studies found for:    "Carcinoma, Small Cell"
Show Display Options
Rank Status Study
21 Completed Hypofractionated Radiotherapy for Small Cell Lung Cancer
Conditions: Lung Neoplasm;   Small Cell Carcinoma
Intervention: Procedure: hypofractionated external beam
22 Terminated Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung;   Carcinoma, Small Cell Lung;   Metastases
Intervention: Drug: zoledronic acid
23 Completed Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG
Condition: Carcinoma, Small Cell Lung
Intervention: Biological: BEC2 Vaccine
24 Unknown  N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Mesothelioma
Interventions: Drug: N-Acetylcysteine;   Drug: Placebo
25 Completed Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer
Conditions: Carcinoma, Small Cell Lung;   Lung Cancer
Interventions: Drug: irinotecan;   Drug: carboplatin;   Drug: bevacizumab;   Procedure: Radiation Therapy
26 Recruiting Metabolomic Analysis of Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung;   Carcinoma, Small Cell Lung
Intervention: Other: 13-C-glucose
27 Completed Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer
Condition: Carcinoma, Small Cell Lung
Interventions: Drug: irinotecan;   Drug: carboplatin;   Drug: bevacizumab
28 Recruiting Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Carcinoma, Thymic
Interventions: Drug: AZD;   Drug: MK-2206;   Drug: Lapatinib;   Drug: Erlotinib;   Drug: Sunitinib;   Procedure: Molecular Profiling
29 Completed The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy
Conditions: Anemia;   Multiple Myeloma;   Lymphoma;   Breast Cancer;   Ovarian Cancer;   Carcinoma, Small Cell Lung;   Esophagus Cancer;   Prostate Cancer;   Neoplasm
Intervention: Drug: epoetin alfa
30 Terminated Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma
Condition: Carcinoma, Small Cell Lung
Intervention: Drug: Glufosfamide
31 Completed Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer
Condition: Carcinoma, Small Cell Lung
Intervention: Drug: Epothilone (BAY86-5302, SH Y03757A)
32 Not yet recruiting ADXS11-001 High Dose HPV+ Cervical Cancer
Conditions: Effects of Immunotherapy;   Metastatic/Recurrent Cervical Cancer;   Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Intervention: Biological: ADXS11-001
33 Unknown  Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer
Condition: Small Cell Carcinoma of Lung
Intervention: Drug: Irinotecan
34 Terminated Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
Conditions: Anemia;   Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small-Cell Lung;   Bladder Cancer;   Cancer of Head and Neck;   Uterine Cervical Cancer
Interventions: Drug: ACE-011 - 15 mg;   Drug: ACE-011 - 30 mg;   Drug: ACE-011 - 45 mg
35 Recruiting Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
Condition: Bladder Cancer
Interventions: Radiation: Prophylactic Cranial Irradiation (PCI);   Other: Brain X-ray
36 Completed Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies
Conditions: Small Cell Carcinoma;   Mesothelioma;   Non-Small-Cell Lung Carcinoma
Interventions: Drug: Decitabine;   Drug: Depsipeptide
37 Suspended Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer
Conditions: Small Cell Carcinoma;   Lung Cancer
Interventions: Drug: Topotecan;   Drug: Sorafenib
38 Completed Cone Beam CT Scanning in Lung and Bladder Cancer.
Conditions: Lung Neoplasm;   Small Cell Carcinoma;   Bladder Carcinoma
Intervention:
39 Completed Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer
Conditions: Lung Neoplasm;   Small Cell Carcinoma
Intervention: Radiation: Hypofractionated Chest Radiotherapy
40 Completed Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer
Interventions: Radiation: brachytherapy;   Radiation: 3-dimensional conformal radiation therapy;   Biological: cetuximab;   Drug: cisplatin

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years